Holen Sie sich die Stockscreener-App
93.33
1.61%
1.395
Schlusskurs vom Vortag:
$91.93
Offen:
$92.25
24-Stunden-Volumen:
58,579
Relative Volume:
0.13
Marktkapitalisierung:
$2.02B
Einnahmen:
$747.40M
Nettoeinkommen (Verlust:
$-12.60M
KGV:
-121.41
EPS:
-0.7687
Netto-Cashflow:
$105.18M
1W Leistung:
-0.88%
1M Leistung:
+1.98%
6M Leistung:
+31.90%
1J Leistung:
+63.18%
1-Tages-Spanne:
$91.04
$93.85
1-Wochen-Bereich:
$90.06
$96.57
52-Wochen-Spanne:
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Firmenname
Ani Pharmaceuticals Inc
Sektor
Telefon
(218) 634-3500
Adresse
210 MAIN STREET WEST, BAUDETTE, MN
Vergleichen Sie ANIP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
93.15 | 2.05B | 747.40M | -12.60M | 105.18M | -0.7687 |
|
ZTS
Zoetis Inc
|
143.15 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.46 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.24 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
447.95 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-03-12 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-11 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-15 | Eingeleitet | CapitalOne | Overweight |
| 2023-08-22 | Bestätigt | H.C. Wainwright | Buy |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-02 | Eingeleitet | Truist | Buy |
| 2020-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-05-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Bestätigt | Canaccord Genuity | Buy |
| 2017-07-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-22 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Eingeleitet | Raymond James | Strong Buy |
| 2016-05-24 | Herabstufung | Standpoint Research | Buy → Hold |
| 2015-11-13 | Eingeleitet | Standpoint Research | Buy |
| 2015-09-28 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Bestätigt | Oppenheimer | Outperform |
| 2015-08-04 | Bestätigt | ROTH Capital | Neutral |
| 2015-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-15 | Bestätigt | ROTH Capital | Neutral |
| 2015-06-23 | Bestätigt | Oppenheimer | Outperform |
| 2015-05-18 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Bestätigt | Oppenheimer | Outperform |
| 2015-04-10 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Bestätigt | ROTH Capital | Buy |
| 2015-02-18 | Bestätigt | Oppenheimer | Outperform |
Alle ansehen
Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
Predicting ANI Pharmaceuticals Inc. trend using moving averagesWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
Smart tools for monitoring ANI Pharmaceuticals Inc.’s price action2025 Market Outlook & Free Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-10-31 02:28:58 - newser.com
Why ANI Pharmaceuticals Inc. (BSFA) stock is a strong buy callWeekly Earnings Recap & Fast Exit/Entry Strategy Plans - newser.com
Regression analysis insights on ANI Pharmaceuticals Inc. performanceWeekly Market Report & Safe Entry Point Alerts - newser.com
ANI Pharmaceuticals (ANIP) to Release Earnings on Friday - MarketBeat
Will ANI Pharmaceuticals Inc. (BSFA) stock boost dividends furtherJuly 2025 Spike Watch & Real-Time Volume Spike Alerts - newser.com
What indicators show strength in ANI Pharmaceuticals Inc.2025 Stock Rankings & Weekly Setup with ROI Potential - newser.com
Can ANI Pharmaceuticals Inc. stock continue upward trend2025 Market Outlook & Momentum Based Trading Ideas - newser.com
Reversal indicators forming on ANI Pharmaceuticals Inc. stockExit Point & Intraday High Probability Setup Alerts - newser.com
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Teacher Retirement System of Texas - MarketBeat
Why ANI Pharmaceuticals Inc. stock could rally in 2025CEO Change & Verified Technical Signals - newser.com
How ANI Pharmaceuticals Inc. stock trades during market volatilityQuarterly Trade Review & Free Community Supported Trade Ideas - newser.com
Mizuho Markets Americas LLC Buys 15,357 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
What high frequency data says about ANI Pharmaceuticals Inc.Weekly Investment Report & Fast Moving Trade Plans - newser.com
ANI Pharmaceuticals Inc Stock Analysis and ForecastMarket Rumors and News & Trade Like a Pro Using AI Edge - earlytimes.in
ANI Pharmaceuticals: Strong Buy On Rare Disease Growth, Record Of Beating Estimates - Seeking Alpha
What dividend safety score for ANI Pharmaceuticals Inc. stockTrade Performance Summary & Low Risk High Win Rate Picks - Fundação Cultural do Pará
Using flow based indicators on ANI Pharmaceuticals Inc.Global Markets & AI Enhanced Trading Alerts - newser.com
Will ANI Pharmaceuticals Inc. stock benefit from automationEarnings Growth Report & Weekly High Potential Stock Alerts - Fundação Cultural do Pará
Will ANI Pharmaceuticals Inc. stock maintain growth storyJuly 2025 PostEarnings & High Win Rate Trade Tips - Fundação Cultural do Pará
Published on: 2025-10-27 13:52:14 - newser.com
ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards? - Nasdaq
Is ANI Pharmaceuticals Inc. stock attractive for growth ETFsTrade Ideas & Risk Controlled Swing Trade Alerts - newser.com
Applying Elliott Wave Theory to ANI Pharmaceuticals Inc.Market Activity Report & Safe Capital Allocation Plans - newser.com
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Published on: 2025-10-26 17:36:11 - newser.com
Published on: 2025-10-26 16:54:24 - newser.com
Published on: 2025-10-26 04:15:09 - newser.com
Published on: 2025-10-25 21:32:31 - newser.com
Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.77%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):